Cell Reports (Mar 2023)

Source of nicotinamide governs its metabolic fate in cultured cells, mice, and humans

  • Tumpa Dutta,
  • Nidhi Kapoor,
  • Meril Mathew,
  • Suban S. Chakraborty,
  • Nathan P. Ward,
  • Nicolas Prieto-Farigua,
  • Aimee Falzone,
  • James P. DeLany,
  • Steven R. Smith,
  • Paul M. Coen,
  • Gina M. DeNicola,
  • Stephen J. Gardell

Journal volume & issue
Vol. 42, no. 3
p. 112218

Abstract

Read online

Summary: Metabolic routing of nicotinamide (NAM) to NAD+ or 1-methylnicotinamide (MeNAM) has impacts on human health and aging. NAM is imported by cells or liberated from NAD+. The fate of 2H4-NAM in cultured cells, mice, and humans was determined by stable isotope tracing. 2H4-NAM is an NAD+ precursor via the salvage pathway in cultured A549 cells and human PBMCs and in A549 cell xenografts and PBMCs from 2H4-NAM-dosed mice and humans, respectively. 2H4-NAM is a MeNAM precursor in A549 cell cultures and xenografts, but not isolated PBMCs. NAM released from NAD+ is a poor MeNAM precursor. Additional A549 cell tracer studies yielded further mechanistic insight. NAMPT activators promote NAD+ synthesis and consumption. Surprisingly, NAM liberated from NAD+ in NAMPT activator-treated A549 cells is also routed toward MeNAM production. Metabolic fate mapping of the dual NAM sources across the translational spectrum (cells, mice, humans) illuminates a key regulatory node governing NAD+ and MeNAM synthesis.

Keywords